Acquisition of Amikacin Resistance during Amikacin Liposome Inhalation Suspension Add-on Therapy for Mycobacterium avium Complex Pulmonary Disease

被引：0
|
作者：
Sano, Hirohito [1 ]
Fujino, Naoya [1 ]
Numakura, Tadahisa [1 ]
Yamada, Mitsuhiro [1 ]
Tode, Naoki [1 ]
Sugiura, Hisatoshi [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan
来源：
ANNALS OF THE AMERICAN THORACIC SOCIETY | 2024年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：526 / 529
页数：4
相关论文
共 50 条
  • [21] A Retrospective Analysis to Assess the Discontinuation of Amikacin Liposome Inhalation Suspension Therapy Among Patients Treated for Refractory Mycobacterium Avium Complex Lung Disease
    Puc, M.
    Koerner, P.
    Russian, A.
    Faris, R.
    Vanscoy, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [22] Amikacin liposome and Mycobacterium avium complex: A systematic review
    Zangiabadian, Moein
    Malekshahian, Donya
    Arabpour, Erfan
    Abadi, Sahel Shafiee Dolat
    Yazarlou, Fartous
    Bostanghadiri, Narjess
    Centis, Rosella
    Aghababa, AmirHossein Akbari
    Farahbakhsh, Mohammad
    Nasiri, Mohammad Javad
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    PLOS ONE, 2022, 17 (12):
  • [23] Management of dysphonia caused by amikacin liposome inhalation in M. avium complex pulmonary disease
    Kurahara, Y.
    Kanaoka, K.
    Tanaka, Y.
    Maeda, Y.
    Kobayashi, T.
    Takeuchi, N.
    Kagawa, T.
    Tachibana, K.
    Yoshida, S.
    Tsuyuguchi, K.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2023, 27 (11) : 872 - 873
  • [24] Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex (MAC) Lung Disease: Effect of Baseline Amikacin and Clarithromycin Susceptibility on Culture Conversion
    Winthrop, K. L.
    Flume, P. A.
    Thomson, R.
    Brown-Elliott, B. A.
    Wallace, R. J., Jr.
    Griffith, D. E.
    Pennings, L. J.
    Coulter, C.
    Syrmis, M.
    Pandey, S.
    Yuen, D.
    Mange, K.
    van Ingen, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [25] Clinical study of 20 cases of refractory Mycobacterium avium complex pulmonary disease treated with amikacin liposomal inhalation suspension
    Kaneko, Taichi
    Hagiwara, Eri
    Okuda, Ryo
    Ogura, Takashi
    RESPIROLOGY, 2024, 29 : 48 - 49
  • [26] EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)
    Winthrop, Kevin
    Eagle, Gina
    Morimoto, Kozo
    Castellotti, Paola Francesca
    O'Donnell, Anne
    Ruoss, Stephen
    Aksamit, Timothy
    Nezamis, James
    Griffith, David
    CHEST, 2018, 154 (04) : 182A - 183A
  • [27] In reply-Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex
    Shulha, Jennifer
    MAYO CLINIC PROCEEDINGS, 2020, 95 (01) : 202 - 202
  • [28] Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium Avium Complex Pulmonary Disease: A Case Report
    Hashimoto, Kazuki
    Nii, Takuro
    Sumitani, Hitoshi
    Yokoyama, Masashi
    Miyamoto, Satoshi
    Mihashi, Yasuhiro
    Nagata, Yuka
    Matsuki, Takanori
    Tsujino, Kazuyuki
    Miki, Keisuke
    Kida, Hiroshi
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 6629 - 6634
  • [29] Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease A 12-Month Open-Label Extension Clinical Trial
    Winthrop, Kevin L.
    Flume, Patrick A.
    Thomson, Rachel
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Morimoto, Kozo
    Ruoss, Stephen J.
    Codecasa, Luigi R.
    Yim, Jae-Joon
    Marras, Theodore K.
    van Ingen, Jakko
    Wallace, Richard J., Jr.
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Griffith, David E.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1147 - 1157
  • [30] Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use (vol 41, pg 405, 2021)
    Hoy, Sheridan M.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (06) : 591 - 591
12345